EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
2.4.2.62 | Adenocarcinoma of Lung |
22310392 |
Association between C3orf21, TP63 polymorphisms and environment and NSCLC in never-smoking Chinese population. |
causal interaction diagnostic usage therapeutic application unassigned |
4 3 3 0 |
2.4.2.62 | Adenocarcinoma of Lung |
28422717 |
C3orf21 ablation promotes the proliferation of lung adenocarcinoma, and its mutation at the rs2131877 locus may serve as a susceptibility marker. |
causal interaction diagnostic usage ongoing research therapeutic application |
4 4 4 1 |
2.4.2.62 | Adenocarcinoma of Lung |
33429795 |
XXYLT1 methylation contributes to the occurrence of lung adenocarcinoma: Methylation and lung adenocarcinoma. |
causal interaction diagnostic usage ongoing research therapeutic application |
4 4 3 2 |
2.4.2.62 | Carcinoma, Non-Small-Cell Lung |
34026596 |
Beta-Elemene Reduces the Malignancy of Non-Small Cell Lung Cancer by Enhancing C3orf21 Expression. |
causal interaction diagnostic usage ongoing research therapeutic application |
1 3 4 4 |
2.4.2.62 | Lung Neoplasms |
28422717 |
C3orf21 ablation promotes the proliferation of lung adenocarcinoma, and its mutation at the rs2131877 locus may serve as a susceptibility marker. |
causal interaction diagnostic usage ongoing research therapeutic application |
4 4 4 1 |
2.4.2.62 | Lung Neoplasms |
34026596 |
Beta-Elemene Reduces the Malignancy of Non-Small Cell Lung Cancer by Enhancing C3orf21 Expression. |
causal interaction diagnostic usage ongoing research therapeutic application |
1 3 4 4 |
2.4.2.62 | Neoplasms |
28422717 |
C3orf21 ablation promotes the proliferation of lung adenocarcinoma, and its mutation at the rs2131877 locus may serve as a susceptibility marker. |
causal interaction diagnostic usage ongoing research therapeutic application |
4 4 4 1 |
2.4.2.62 | Neoplasms |
33429795 |
XXYLT1 methylation contributes to the occurrence of lung adenocarcinoma: Methylation and lung adenocarcinoma. |
causal interaction diagnostic usage ongoing research therapeutic application |
4 4 3 2 |
2.4.2.62 | Neoplasms |
34026596 |
Beta-Elemene Reduces the Malignancy of Non-Small Cell Lung Cancer by Enhancing C3orf21 Expression. |
causal interaction diagnostic usage ongoing research therapeutic application |
1 3 4 4 |